Dr. Benjamin D. Schwartz, MD

Dr. Schwartz practices at Washington University School of Medicine in Saint Louis, Missouri.

Dr. Schwartz's NPI, 1275550782, was assigned on July 17, 2006. Dr. Schwartz graduated from Albert Einstein College of Medicine of Yeshiva University in 1972. Dr. Schwartz holds Missouri license R7313.

Dr. Schwartz's primary practice is Washington University School of Medicine, at 4921 Parkview Pl, Saint Louis, MO 63110 in Saint Louis City. The practice phone is (314) 747-5192.

Dr. Schwartz's primary practice is Washington University School of Medicine in Saint Louis, Missouri. Dr. Schwartz is also affiliated with Barnes-Jewish Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Schwartz to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schwartz practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Schwartz's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Schwartz is licensed in Missouri.

CMS data shows 75 Medicare services from Dr. Schwartz across 3 procedure codes in 2024, for 56 Medicare patients. Medicare paid $1,663 for them. Every service was in an office.

CMS counts 56 Medicare patients who saw Dr. Schwartz in 2024. The largest group is 65 to 74, with 29 patients. 71% of them have high blood pressure, and 66% have arthritis. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schwartz's median patient age at 68, with 66% women.

In 2024, Dr. Schwartz wrote 718 Medicare Part D claims for 41 patients. 79% of them were for generic drugs. CMS names the drug for 546 of them, across 20 drugs with 11 or more claims each, at $583,409 in total drug cost. In 2023, CMS named 566 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Schwartz for performance year 2024, reported as part of a group. Dr. Schwartz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Schwartz, published from 2015 to 2023. 2019 was the busiest year, with 2. The most frequent topics are Administration, Oral, Anti-Inflammatory Agents and COVID-19. Dr. Schwartz has published most often in Vaccine. Dr. Schwartz's most frequent co-authors are Richard Sanford Finkel, MD, Nancy Lynn Kuntz, MD and Edward C. Smith, MD.

CMS Open Payments shows 40 general payments to Dr. Schwartz from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 99% of the total. Pfizer Inc. paid the most, $388,935.

Dr. Schwartz graduated from Albert Einstein College of Medicine of Yeshiva University in 1972.